POWERbreathe is an Inspiratory Muscle Trainer, exercising and strengthening the muscles we use to breathe.

Inspiratory Muscle Training (IMT) is scientifically proven to benefit patients with respiratory illness and healthy people, including athletes at all levels of competition, including Olympians.

An overview of benefits and results from laboratory trials are listed below. For specific benefits, research references and clinical and laboratory trials that support the findings click here to see the Powerbreathe website.

Sports & Exercise

• Improved inspiratory muscle strength by 31.2%
• Improved inspiratory muscle endurance by 27.8%
• Accelerated recovery during repeated sprints by up to 7%
• Improved cycling time trial performance by 4.6% - equivalent to slashing 3-minutes off a 40k time trial
• Enabled participants to cycle for 33% longer and with lower sense of effort
• Improved rowing time trial performance by up to 2.2% - equivalent to slashing 60m in a 2km race
• Increased swimming performance by up to 3.5%
• Reduced whole body effort during exercise
• Warmed-up the breathing muscles & significantly improved rowing performance and reduced breathlessness in competitive rowers
• Warmed-up the breathing muscles which normal warm-up routines fail to do

• Speeded-up lactate clearance more effectively than traditional active recovery strategies

Performers

• Enhanced the ability to inflate the lungs (take deeper breaths)
• Enhanced the ability to control the breath
• Enhanced the ability to sustain forceful breathing (breathing does not become fatigued)
• Training may affect the intrinsic laryngeal muscles which control the action of the larynx

• Warms-up the breathing muscles prior to rehearsal or performance

Health & Medical

• Reduced breathlessness & restored breathing power
• Increased inspiratory muscle strength by up to 45%
• Improved quality of life in people with major debilitating conditions
• Enhanced exercise tolerance in people with major debilitating conditions
• Reduced consumption of medication of up to 79% in asthma patients
• Reduced ß2-agonists consumption by up to 79% in patients with asthma
• Showed an improvement in asthma symptoms by up to 75% in 3 weeks
• Improvements in inspiratory muscle strength of 55% in patients with Chronic Obstructive Pulmonary Disease (COPD)
• Improvements in endurance of 86% in patients with Chronic Obstructive Pulmonary Disease (COPD)
• Improvements in quality of life by 21% in patients with Chronic Obstructive Pulmonary Disease (COPD)

• Improvements in dyspnoea by 36% in patients with Chronic Obstructive Pulmonary Disease (COPD)

Uniformed Services

• Improved breathing conditions in people with physically demanding occupational situations where breathing demand is raised or where breathing apparatus is used, such as the Armed Forces, Police Force and Fire Service
• Improved inspiratory muscle strength by 31.2%
• Improved inspiratory muscle endurance by 27.8%
• Reduced breathlessness
• Reduced heart rate
• Reduced the rate of air use from the breathing cylinder used by firefighters (increasing wear time by around 1.5 min from a 15 min cylinder)
• Increased time to exhaustion during a standard laboratory treadmill test